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Fibroblast growth factor receptors (FGFRs) regulate
diverse cellular behaviors that should be exquisitely
controlled in space and time. We engineered an
optically controlled FGFR (optoFGFR1) by exploiting
cryptochrome 2, which homointeracts upon blue
light irradiation. OptoFGFR1 can rapidly and revers-
ibly control intracellular FGFR1 signaling within sec-
onds by illumination with blue light. At the subcellular
level, localized activation of optoFGFR1 induced
cytoskeletal reorganization. Utilizing the high spatio-
temporal precision of optoFGFR1, we efficiently
controlled cell polarity and induced directed cell
migration. OptoFGFR1 provides an effective means
to precisely control FGFR signaling and is an
important optogenetic tool that can be used to
study diverse biological processes both in vitro
and in vivo.
INTRODUCTION
Fibroblast growth factor receptors (FGFRs) are highly conserved
receptor tyrosine kinases that bind to fibroblast growth factors
(FGFs). The FGF family is the largest group of growth factors,
with 22 members and 7 groups in humans (Itoh and Ornitz,
2004), and they regulate diverse biological events, including
development, wound healing, and angiogenesis (Klint and
Claesson-Welsh, 1999). Upon binding with FGFs, FGFRs
dimerize and trans-autophosphorylate multiple tyrosine resi-
dues, thereby providing docking sites for downstream compo-
nents such as phosphatidylinositol 3-kinase (PI3K), mitogen-
activated protein kinase (MAPK), and phospholipase C (PLC)
(Mohammadi et al., 1996).
The FGFR-FGF interactions have complex properties because
of the promiscuous binding of FGF to the different FGFR iso-
forms (Turner and Grose, 2010). Moreover, the activities of
FGFRs are intricately controlled by distinct interactions with
FGFs and cofactors in a defined space and time (Powers et al.,
2000). Given these properties of FGFR, promiscuous binding
and spatiotemporal regulation, it is difficult to delineate the spe-Chemistry & Biology 21,cific role of each isoform in a certain biological context, which
gives rise to the need for a tool capable of specifically and pre-
cisely regulating the FGFR system. To date, many approaches
have been introduced to study FGFR signaling pathways.
Despite extensive use in previous research, recombinant pep-
tides of FGF ligands exhibit complex effects because of their
redundant binding to FGFR isoforms. Genetic perturbation
studies, represented by overexpression and knockout strate-
gies, have tried to elucidate the specific function of FGF-FGFR
systems. However, these methods have practical difficulties,
such as delayed responses and constitutive alterations in gene
expression (Stockwell, 2000).
The chemically induced dimerization (CID) system is one
alternative for compensating for those drawbacks. The genet-
ically engineered CID system is based on a concept in which
the proximity between target proteins can be increased
through the engineered docking site by a pharmacological
dimerizer (Neff and Blau, 2001). This method has proven to
be useful for elucidating the roles of specific types of receptors
in various biological events. For example, chimeric FGFR sub-
types fused with mutated FK506 binding protein showed the
distinct effects of individual receptors on the progression of
breast and prostate cancer (Freeman et al., 2003; Xian et al.,
2005). However, these tools also have limitations that are com-
mon with chemically based approaches, such as potential side
effects from the addition of exogenous small molecules, low
reversibility, a prolonged diffusion time of substances, and
low spatial precision.
Optogenetic approaches, which have been developed and
expanded rapidly in application over the last few years, have
been suggested as powerful means to overcome these limita-
tions. Meanwhile, various photo-inducible proteins have been
introduced to regulate protein interaction by light stimulation
(Levskaya et al., 2009; Wu et al., 2009). One is the photolyase
homology region from the photosensory protein cryptochrome
2 (CRY2PHR) of Arabidopsis thaliana. This protein undergoes a
conformational change and promotes homointeraction upon
blue light illumination (Yu et al., 2009). CRY2PHR is an enticing
optogeneticmodule for use in optogenetic studies of intracellular
signaling in mammalian systems (Bugaj et al., 2013) because of
its fast responsiveness with subsecond time resolution, subcel-
lular spatial resolution, and no need for exogenous cofactors
(Kennedy et al., 2010).903–912, July 17, 2014 ª2014 Elsevier Ltd All rights reserved 903
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Figure 1. Generation and Characterization of OptoFGFR1
(A) Schematic representation of wild-type (WT) FGFR1 and optoFGFR1.
(B) Design of the optoFGFR1 construct. The cytoplasmic region of FGFR1 (amino acids 398–822) was inserted between the myristoylation signal peptide (Myr)
and CRY2PHR. TM, transmembrane region; mCit, mCitrine.
(C–E) Fluorescence images of HeLa cells expressing optoFGFR1 (yellow) and biosensors (red) for (C) the PLCg pathway, R-GECO1; (D) the ERK pathway, ERK-
dTomato; and (E) the PI3K pathway, dTomato-PHAKT. The cells were illuminated by continuous blue light (488 nm, 7 mW) with or without treatment of an FGFR-
specific kinase inhibitor (SU5402). The quantified results in the right panel of each image show the normalized cytoplasmic intensity of R-GECO1, the relative
intensity of the cytoplasm (cyto, empty bar), and the nucleus (nuc, gray bar) of ERK-dTomato and line intensity histograms of dTomato-PHAKT fluorescence
intensity across the white dotted arrows in gray (before light stimulation) and blue (after light stimulation).
Scale bars, 10 mm. See also Figures S1 and S2.
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Optogenetic Control of FGFR SignalsIn this study, we developed a light-inducible chimeric
receptor, called optoFGFR1, by utilizing CRY2PHR as a regula-
tory component and attaching it to the cytoplasmic region of
FGFR1 under the rationale that the homointeraction property of
CRY2PHR is sufficient to activate FGFR1. Through this technol-
ogy, we present the spatiotemporal regulation of the FGFR signal
and also highlight the role of optoFGFR1 in regulating membrane
protrusion and the direction of migrating cells.
RESULTS
Generation of Light-Inducible FGFR1
We designed a light-inducible module for activating FGFR sig-
nals by use of the light-dependent homointeractive domain
PHR from cryptochrome 2 (CRY2PHR). In particular, we hypoth-
esized that light-inducible homointeraction of CRY2PHR would
bring FGFR1s into close proximity, leading to activation of the
receptor even in the absence of its ligand (Figure 1A). This opto-
genetic module, optoFGFR1, consists of CRY2PHR (amino
acids 1–498) (Kennedy et al., 2010), the cytoplasmic region of
human FGFR1 (amino acids 398–822), and a myristoylation
signal peptide (Figure 1B).904 Chemistry & Biology 21, 903–912, July 17, 2014 ª2014 Elsevier LLight-Induced Activation of FGFR1 Signaling Pathways
by OptoFGFR1
We initially performed time-lapse live cell imaging to examine the
functionality of optoFGFR1 by confirming that light activates the
canonical FGFR pathways. To activate optoFGFR1 via light-
induced CRY2PHR homointeraction, blue light (488 nm, 7 mW)
was illuminated onto HeLa cells coexpressing optoFGFR1 and
each optical biosensor for distinct FGFR canonical pathways:
R-GECO1 (Zhao et al., 2011), ERK-dTomato, and dTomato-
PHAKT, reflecting the PLCg, MAPK, and PI3K pathways, respec-
tively. After illumination, ERK-dTomato and dTomato-PHAKT
were translocated into the nucleus and on the plasma mem-
brane, respectively, and the fluorescence intensity of
R-GECO1 was increased in optoFGFR1-expressing cells (Fig-
ures 1C–1E). Under the same conditions, there was no change
in these signals after treatment with SU5402, a FGFR-specific
tyrosine kinase inhibitor (Figures 1C–1E, bottom panel). For veri-
fication of signal specificity, we constructed two optoFGFR1
mutants: a PLCg binding mutant of optoFGFR1 (Y766F) (Mo-
hammadi et al., 1991) and CRY2PHR-deleted optoFGFR1
(DCRY2PHR). The Y766F and DCRY2PHR mutants could not
elevate the R-GECO1 signal regardless of light illumination,td All rights reserved
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Figure 2. Spatiotemporal Control of FGFR1 Downstream Signals by
Light
(A) Changes in three downstream pathways of optoFGFR1 expressing HeLa
cells after a single pulse of light (488 nm, 7 mW).
(B) Reversible and individual activation of PLCg signals in HeLa cells expessing
optoFGFR1. Cells were sequentially and repeatedly illuminated with blue light
(488 nm, 1 mW) as illustrated in the upper left panel and upper right gray bar
(blue square, time of illumination). Kymograph of R-GECO1 intensity drawn
along the dashed white line is in the upper right panel. Lower panel images
show maximal R-GECO1 responses of each cell after activation. Stim. area,
stimulated area; R, repeated stimulation.
Scale bars, 10 mm. See also Figures S3 and S4 and Movie S1.
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Optogenetic Control of FGFR Signalsimplying that CRY2PHR-dependent homointeraction of cyto-
plasmic FGFR1 is sufficient for activation of FGFR signaling (Fig-
ure S1A available online). We also evaluated the functionality of
optoFGFR1 by comparing the phosphorylation of ERK in
optoFGFR1-expressing HeLa cells that were illuminated for 5
or 15 min with nontransfected HeLa cells treated with bFGF
(10 ng/ml) for 5 or 15 min. Compared with the basal state, there
were remarkable increases in the phosphorylation of ERK1/2
that were sustained in all time periods in the bFGF-treated cells
and the illuminated cells (Figure S1B). These results suggest that
three major pathways of FGFR could be readily and specifically
activated through optoFGFR1 upon light exposure.
An increase of proximity between receptors upon dimerization
is the key process in the activation of receptor tyrosine kinases
(Hubbard and Till, 2000). To visualize the increase of proximity
between optoFGFR1 upon light illumination, we conducted a
fluorescence resonance energy transfer (FRET) assay in cells
coexpressing mCitrine- and mCerulean-tagged optoFGFR1
(Figure S1C). Upon light illumination, we not only observed a
significant increase in FRET signal after light illumination (Fig-
ure S1D; p < 0.001) but also observed clustering of optoFGFR1
on the basal cell membrane through total internal reflection
fluorescence (TIRF) microscopy (Figure S1F). These results
provide direct evidence of the homointeraction property of
optoFGFR1 upon light illumination. Notably, these results could
not be observed with optoFGFR1 containing a light-insensitive
CRY2PHR mutant, CRY2PHR(D387A) (Liu et al., 2008) (Figures
S1D and S1F), implying that homointeraction of optoFGFR1 is
mainly induced by CRY2PHR.
Under physiologically relevant conditions, activation of FGFR
via ligands leads to receptor internalization and ubiquitination
(Wong et al., 2002) and to signaling alterations because of
changed localization (Wiley and Burke, 2001). Therefore, we
investigated whether light-induced activation of optoFGFR1 un-
dergoes the same internalization process. In particular, we
compared the localization patterns of optoFGFR1 with those
of the Rab5b small GTPase, which is involved in the trafficking
of the FGFR signaling complex (Sandilands et al., 2007), at
certain time periods (0, 20, and 40 min) after light illumination.
Within 20 min after illumination, optoFGFR1 formed small
puncta and colocalized into early endosomes marked by
mRFP-Rab5b. Over time, those complexes accumulated
adjacent to the nucleus (Figures S2A and S2C). However,
optoFGFR1 without the cytoplasmic FGFR1 region (DFGFR1)
was not colocalized with Rab5B and did not show any punctum
formation and translocation despite light stimulation. These
results indicate that optoFGFR1 can be internalized following
light stimulation and that this process is mainly dependent
on the activated cytoplasmic FGFR1 region (Figures S2B
and S2D).
Taken together, our light-responsive chimeric protein,
optoFGFR1, is not only efficient and specific in inducing the acti-
vation of FGFR signaling by light illumination but also biologically
relevant to the wild-type FGFR1.
Spatiotemporal Regulation of FGFR Signaling pathways
by Illumination
The ability to precisely control cellular functions with high
spatial and temporal resolution is one of the main advantagesChemistry & Biology 21,of optogenetics. Therefore, we characterized optoFGFR1
based on the high spatiotemporal resolution of light exposure,
reversibility of the system, and versatility of the intracellular
signaling. First of all, we assessed the temporal resolution of
optoFGFR1. HeLa cells coexpressing optoFGFR1 and each
biosensor for one of three canonical pathways were stimulated
with a single pulse of blue light (0.5 s), and signal changes were
monitored simultaneously. Under brief light exposure, all three
pathways, PLCg, PI3K, and MAPK, were transiently activated
in minutes (Figure 2A). Next, we evaluated the spatial precision
and reversibility of optoFGFR1. We utilized R-GECO1 as an
indicator to clearly visualize the on/off transition of PLCg
signaling in two adjacently located cells. Blue light was given
sequentially to each cell, and each cell in the region of903–912, July 17, 2014 ª2014 Elsevier Ltd All rights reserved 905
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Figure 3. Fine-Tuned FGFR1SignalingActivity throughDiverse Light
Inputs
(A) The change of ERK signaling kinetics according to the frequency of
photostimulation. HeLa cells coexpressing optoFGFR1 and ERK-dTomato
were either treated with bFGF (10 ng/ml) or illuminated repeatedly (488 nm,
7 mW) at 10-, 30-, and 60-min intervals (n > 6). Gray and blue arrows represent
time points of bFGF treatment and light illumination, respectively. nuc,
nucleus; cyto, cytoplasm.
(B) The effect of the duty cycle of photostimulation on the magnitude of ERK
translocation in HeLa cells. Blue light was applied for 0, 0.2, 1, 2, and 10 min,
which corresponds to 0%, 1%, 5%, 10%, and 50% of duty cycles (percentage
of illumination duration/total period; see Experimental Procedures). The graph
in the right panel shows the change of ERK translocation over a time period of
20 min.
Error bars indicate SEM.
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Optogenetic Control of FGFR Signalsillumination responded immediately. The level of calcium
increased repeatedly in a similar manner during the second cy-
cle of illumination (Figure 2B; Movie S1).
To evaluate the responsiveness of optoFGFR1, the activation
kinetics of light-mediated FGFR1 signaling were compared with
those of the existing, chemically induced approach. We con-
structed additional FGFR signaling activator protein, inducible
human FGFR (ihFGFR1), which can be activated by treatment
with a chemical dimerizer, AP20187 (Welm et al., 2002) (Fig-
ure S3A). After treatment with AP20187 or continuous illumina-
tion, we quantified the change of fluorescence intensity over
time for each biosensor of canonical pathways and calculated
the half-maximal time for activation (Ta1/2, see Experimental
Procedures). The activation kinetics of canonical signaling
pathways by ihFGFR1 were significantly slower than those of
optoFGFR1 (p < 0.005; Figures S3B–S3E), probably because
of the time required for diffusion. The rapid change of signaling
pathways clearly demonstrates the fast response of optoFGFR1.
Moreover, we found that signaling kinetics were affected by
the expression level of optoFGFR1 and light intensity, although
the magnitude of activation was not affected. The activation
kinetics of PLCg signaling became faster as the light intensity
or expression level of optoFGFR1 increased (Figure S4). We
also observed that the deactivation kinetics were faster in cells
with fast activation kinetics, implying a possible negative
feedback mechanism in the signaling pathway (Taylor, 1998).
Versatile Control of Signaling Dynamics by Modulation
of Illumination
Transient versus sustained activation of signaling pathway has
been regarded as the determinant of signaling specificity, espe-
cially in the ERK pathway (Marshall, 1995). Therefore, we moni-
tored the change of ERK signaling kinetics according to the
frequency or duty cycle of photostimulation in HeLa cells ex-
pressing optoFGFR1. Various ERK translocation patterns were
observed in response to photostimulation with 10- to 60-min
intervals. The minimal interval of time, 10 min, was determined
by the results from a previous report on dissociation kinetics of
CRY2PHR clusters (decay constant, 5.4 ± 0.4 min) (Bugaj
et al., 2013). At the highest frequency, 10 min, repeated stimula-
tion of optoFGFR1 elicited an accumulation of ERK in the
nucleus for longer than 2 hr, and the sustained level was similar
to that seen with bFGF treatment (Figure 3A, upper panels). With
lower frequencies (30- and 60 min intervals), ERK kinetics
showed transient and pulsatile patterns, and the cyclic period
corresponded with its interstimulus interval (Figure 3A, lower
panels).
To investigate the effect of the duty cycle, we applied blue light
with various durations within a period of 20 min (1%–50% duty
cycles). Interestingly, the major factor of ERK signals affected
by varying duty cycles was not kinetics but the magnitude of
activity. Nuclear ERK intensity was increased 4-fold as the
duty cycle increased up to 50% (Figure 3B). This increasing
pattern upon continuous illumination seems to result from the
characteristics of CRY2PHR because a similar pattern was
observed in a previous report (Bugaj et al., 2013). Taken
together, these observations demonstrate that optoFGFR1
can distinctly regulate signaling pathways depending on the
frequency and duration of light stimulation.906 Chemistry & Biology 21, 903–912, July 17, 2014 ª2014 Elsevier LRegulation of Cell Polarity through optoFGFR1
Next, we identified the effect of optoFGFR1 on specific cell func-
tions in which multiple signal pathways are orchestrated. FGF is
one of several crucial factors in angiogenesis, especially in the
actin-based motility of endothelial cells (Lamalice et al., 2007).
Moreover, it is well known that endothelial cells, regardless of
their origin, mainly express FGFR1 (Bastaki et al., 1997). We
reasoned that precise activation of FGFR1 through optoFGFR1
could dissect complex signaling pathways involved in cell migra-
tion and reveal the specific role of FGFR1 in this response.
Accordingly, we selected human umbilical vein endothelial cells
(HUVECs) that were transfected with mCherry-Lifeact (Riedl
et al., 2008) and optoFGFR1 as a model system for visualizing
cytoskeletal changes related to cell motility upon optoFGFR1
activation. After serum starvation, transfected HUVECstd All rights reserved
Figure 4. Light-Induced Membrane Protrusion and Cell Polarization
(A) Morphological changes of HUVECs coexpressing optoFGFR1 and mCherry-Lifeact that were treated with bFGF (100 ng/ml) (+ bFGF), unilluminated ( Light),
or illuminated with blue light (488 nm, 7 mW, and 30 s intervals) (+ Light). The right panel shows protrusions and retractions at 0 and 30 min (red, protrusion; blue,
retraction; white, overlapping area).
(B) Polarity change upon partial stimulation by light. Repeated partial stimulation (488 nm, 1 mW, and 30 s intervals) was applied to the peripheral region of
a HUVEC. Two different sites (light blue region, S1 or S2) were illuminated sequentially, and adjacent linear regions (white dotted line, a and b) were drawn by the
kymograph (upper right panel). The light-induced change in cell morphology is presented as a protrusion/retraction graph in the lower panel (red, protrusion; blue,
retraction; white, overlapping area; light blue, illuminated point).
(C) Changes in stress fiber distribution during partial light stimulation in Figure 4B. mCherry-Lifeact images are illustrated by a pseudocolored intensity image that
focused on actin filaments (upper panel). This image clearly shows concentrated actin filaments at opposite sides of the illuminated area (red arrow) and that the
whole cell region is divided into two distinct parts (yellow and blue dotted squares, R1 and R2), with separate quantification of the amounts of actin bundles in
each part.
(D) Quantified amount of actin bundles in two distinct regions (R1 and R2) during the S1 and S2 stimulation (stim.) phases. AU, arbitrary unit.
Scale bars, 20 mm. See also Movie S2.
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Optogenetic Control of FGFR Signalspresented spontaneous and intermittent protrusion-retraction
cycles covering the entire cell boundary (Tkachenko et al.,
2011). Uponeither bFGF (100ng/ml) treatment or repeated illumi-
nation (30 s intervals) of the whole cell area, global lamellipodia
were induced around the entire cell edge (Figure 4A), demon-
strating a general effect of FGFR1 activation on actin remodeling
in a physiological context.
We next examined the effect of local delivery of light in
HUVECs coexpressing optoFGFR1 and mCherry-Lifeact.
Repeated blue light illumination of a small area of the cell peri-Chemistry & Biology 21,phery (S1, 5 mm radius) induced lamellipodia that were localized
around the region of illumination (Figure 4B). Interestingly, there
was a simultaneous retraction of the membrane in the region
opposite the illumination spot (Figure 4B, protrusion/retraction
map; Movie S2), suggesting that asymmetric activation
of FGFR1 in a single cell establishes cell polarity. When the illu-
mination spot was shifted to a different region of the same cell,
the polarity was changed according to the position of light expo-
sure (Figure 4B). Moreover, we could visualize the dynamic
assembly and disassembly of thick actin fibers at the opposite903–912, July 17, 2014 ª2014 Elsevier Ltd All rights reserved 907
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Figure 5. Light-Induced Directed Cell Migration and Related Signaling Pathways
(A) OptoFGFR1-mediated phototaxis model. Circular blue light (160 mm radius, blue dotted circle) was applied to the center of the imaging field (488 nm, 30 mW,
and 30 s intervals) in which HUVECs expressing optoFGFR1 and mCherry-Lifeact were sparsely plated and serum-starved (6 hr). Cell movement was monitored
for 20 hr and compared with the group without light illumination (white dotted circle).
(B) Schematic illustrating the methods used to determine migration angle (q) and directionality (cos q).
(C) Distribution of migration angles in a group of cells with and without light stimulation. Cells were classified by migration angle, measured as the angle between
cell displacement and the center of the light, as in Figure 5B. The percentage of the cells that were kept in darkness ( Light, n = 87) and illuminated (+ Light,
n = 150) is plotted in an angular histogram.
(D) Comparison of the directionality (cos q) of optoFGFR1-expressing HUVECs with inhibition of three different pathways (n > 30 in all groups). Cells were illu-
minated with blue light on the circular region. The FGFR signaling pathways were inhibited using a CRY2PHR deletion (DCRY2PHR), Y766F mutation, 50 mM
LY294002, and 50 nM PD0325901. A directionality value near 1 indicates that cells moved toward to the center of the light. Asterisks indicate significant
differences (*p < 0.05, **p < 0.005). Error bars indicate SEM.
Scale bars, 100 mm. See also Figure S5 and Movies S3 and S4.
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Optogenetic Control of FGFR Signalsside of the illuminated region and in the area of light exposure,
respectively (Figure 4C). A quantified amount of actin bundles
in two distinct regions (the region of light stimulation and
the opposite side) also clearly indicates that the distribution of
actin bundles was largely dependent on the region of illumination
(Figure 4D). This asymmetric distribution of actin fibers provides
important evidence for protrusive and retractile dynamics
in different regions of a cell induced by optoFGFR1. In short,
we confirmed that light-induced global or local activation
of optoFGFR1 induces the dynamic changes in the actin
cytoskeleton represented by formation of lamellipodia and
stress fibers, and reorganization of cell polarity. With these re-
sults, we strongly emphasize that optoFGFR1 facilitates the
fine-tuned and precise spatial activation of FGFR1 on a subcel-
lular level.908 Chemistry & Biology 21, 903–912, July 17, 2014 ª2014 Elsevier LLight-Induced Directed Cell Migration by OptoFGFR1
We hypothesized that protrusive and polarized morphological
changes induced by optoFGFR1 suggest the possibility that
directed cell migration can be induced through local illumination.
To confirm this conjecture, we designed a ‘‘phototaxis model’’ in
which optoFGFR1-expressing cells are guided into a circular
field of blue light (160-mm radius) (Figure 5A). HUVECs cotrans-
fected with optoFGFR1 and mCherry-Lifeact were sparsely
plated and subjected to serum starvation before tracking their
movement based on the center of the nucleus. Interestingly,
the cells consistently migrated toward the illuminated area (Fig-
ure 5A; Movie S3) for 20 hr, whereas the cells in a field without
light exposure moved in random directions (Figure 5A; Movie
S4). Notably, prolonged light stimulation did not have an adverse
effect on cell viability (Figures S1G and S1H). We sought totd All rights reserved
Chemistry & Biology
Optogenetic Control of FGFR Signalsquantify the cell movement by measuring the migration angle (q),
defined as the angle between two paths regarding either
displacement of each cell or the segment connecting the start
point of the cell to the center of the illuminated region (Figure 5B).
An angular histogram, which depicts the distribution of migration
angles, clearly demonstrates the tendency of cells to migrate to-
ward the illuminated region (Figure 5C), indicating that FGFR1
signaling can determine the directionality of migrating cells.
Three major signaling pathways of FGFR1, MAPK, PLCg, and
PI3K, are known to be related to directionality in various cell
types (Shi et al., 2011; Tsai et al., 2014; Welf et al., 2012). With
the optoFGFR1-mediated phototaxis model, we investigated
the contributions of these signaling pathways to controlling the
direction of migrating cells by measuring directionality (cos q,
Figure 5B) of HUVECs under three distinct conditions: point
mutation to inhibit PLCg (Y766F), treatment with a PI3K inhibitor
(LY294002), and treatment with a MAPK inhibitor (PD0325901).
Compared with the cos q of HUVECs with only light stimulation,
the directionality was decreased by Y766F mutation and
LY294002 treatment, whereas PD0325902 treatment hardly
induced any changes in directionality (Figure 5D). These results
indicate that the PI3K and PLCg pathways are actively involved
in regulation of directionality, in which the PI3K pathway seems
to have the most significant role (p < 0.05). Nevertheless, inhibi-
tion of any one of these pathways did not lead to a complete loss
of cell directionality, as shown by cells expressing optoFGFR1
without light ( light) or expressing optoFGFR1 without
CRY2PHR (DCRY2PHR). This implies that a complex and
harmonized network among multiple signaling pathways is
orchestrated to determine direction during cell migration (Ridley
et al., 2003).
To identify the relationship of themotile properties during light-
induced cell migration, we selected cells in which the total dis-
tance ofmigration was greater than 100 mm,which is the average
length of a HUVEC. The overall distance from the center of the
region of illumination (ROI) to the cells reduced constantly
upon repeated light stimulation (Figure S5A), providing direct ev-
idence of the phototactic movement of cells. Near the ROI where
cells were partially illuminated, directionality toward the ROI
increased without significantly affecting migration speed. How-
ever, when cells arrived inside the ROI (where they were illumi-
nated entirely), their directionality decreased rapidly and,
simultaneously, migration speed increased (Figures S5B and
S5C). Collectively, these results confirm that the PI3K and
PLCg pathways are actively involved in determining the direc-
tionality of migrating HUVECs and that FGFR1 signaling differen-
tially regulates the directionality and speed of migrating cells,
depending on the pattern of activation (Figure S5E).
DISCUSSION
In this study, we generated an optogenetic protein, optoFGFR1,
that enables the precise, rapid, and reversible activation of
FGFR1 signaling pathways using blue light. In particular, with
optoFGFR1 and fine-tuned light exposure, we were able to
analyze temporal information of FGFR downstream pathways.
Especially the activity of optoFGFR1 could be distinctly regu-
lated because the kinetics and amplitude of the signal are mainly
dependent on the modulation pattern of light.Chemistry & Biology 21,Our experiments with optoFGFR1-transfected HUVECs also
showed that light stimulation of subcellular regions led to the
dissociation of actin fibers and induction of lamellipodia at the
site of illumination, leading to a change in cell polarity (Figures
4B–4D). These phenomena seem to be related to local changes
in the activities of Rho GTPases, such as Rac and RhoA, that are
mainly associated with the PI3K pathway (Fera et al., 2004). Rho
GTPases are reported to be involved in lamellipodial protrusion
in the leading edge of migrating cells (Ridley et al., 1992; Wu
et al., 2009) and in the disassembly of stress fibers, in which
cofilin plays a major role in accelerating F-actin turnover
(Delorme et al., 2007), which provides a simple explanation for
our observation in active remodeling of stress fibers by local de-
livery of light. In addition, the increase in directionality induced by
optoFGFR1 was dependent on the activity of the PI3K pathway.
When cells arrived in the light-stimulated area, the directionality
was lost, and the migration speed increased. This further
suggests a central role of PI3K-Rho GTPases in light-induced
cell migration because Rac is reported to be a switch that con-
trols directional persistence and speed in cell migration (Pankov
et al., 2005).
Our optoFGFR1-mediated phototaxis model revealed that
FGFR signaling can differentially regulate themode of cell migra-
tion, depending on the activation patterns (symmetric or asym-
metric; Figure S5E). These findings provide insights into the
debate about whether FGFR signals contribute to the direction-
ality or speed (i.e., chemotaxis or chemokinesis) of migrating
cells, a question that has been difficult to resolve by use of other
migration assays (Barkefors et al., 2008). The Boyden chamber
assay, scratch wound healing assay, under-agarose assay,
and microfluidic devices are used frequently to study cell migra-
tion. However, these methods cannot provide detailed spatial
and temporal data for a single cell because of their low sensitivity
and efficiency (Kramer et al., 2013). On the other hand, our
phototaxis model provides accurate information about individual
migrating cells through time-lapse imaging, is highly efficient
(Movie S3), and has potential for use in diverse cell types. In addi-
tion, compared with microfluidic devices, our phototaxis model
is free of fluidic shear stress, and guidance cues can be pro-
duced in two or more dimensions with precise resolution.
There are optogenetic tools that regulate individual down-
stream growth factor signals, such as Ras/Erk, based on the
interaction between phytochrome-PIF (Toettcher et al., 2013)
and PI3K pathways using cryptochrome 2-CIB (Idevall-Hagren
et al., 2012). Compared with these techniques, optoFGFR1 is a
hierarchically different tool, modulating the initiation of signaling
pathways. The activation of optoFGFR1 can regulate multiple
signaling pathways at once, leading to feedback systems and
crosstalk among signals, thereby reproducing a more physio-
logic state. This can be an efficient way to reveal the combinato-
rial effect in a biological context. As exemplified in experiments
using the phototaxis model, introducing a point mutation or
treating inhibitors could allow us to see the role of each down-
stream signaling pathway of FGFR in determining the direction-
ality of migrating cells (Figure 5D).
OptoFGFR1 has a potential for use in many different biological
systems. Along with improvements in optical technology,
including wireless in vivo optical devices (Kim et al., 2013), op-
toFGFR1 has a potential for use in various experimental models903–912, July 17, 2014 ª2014 Elsevier Ltd All rights reserved 909
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necessary. In addition, recent discoveries have expanded the
scope of FGF biology from proliferative and migratory functions
to regulation of metabolism and behavior through the endocrine
system (Bookout et al., 2013; Potthoff et al., 2012), extending the
possible biological application of optoFGFR1. OptoFGFR1 is a
chimeric protein, and the CRY2PHR domain can function as an
independent module. Therefore, our basic design can be gener-
alized to build activating modules for other RTKs and receptor
families.
In conclusion, we provide a tool for regulating specified FGFR
activity by light, optoFGFR1, allowing studies of the function and
downstream process of FGFR through spatiotemporal and pre-
cise control of its activity. OptoFGFR1 is a potentially powerful
tool that can be used to elucidate FGFR signaling mechanisms
in diverse aspects of biology.SIGNIFICANCE
To date, various synthetic modules for the regulation of pro-
tein activity have been introduced to investigate the exact
function of proteins and related signaling pathways. The
optogenetic approach has been developed recently to regu-
late protein activity by introducing diverse photoactivatable
modules represented by CRY2PHR from Arabidopsis thali-
ana. This optical approach has outstanding advantages,
such as high spatiotemporal resolution, minimal side
effects, and suitability for animal models. Here we provide
an optogenetic regulatory module for FGFR signaling,
optoFGFR1, in which blue light induces FGFR activation
based on homointeraction of CRY2PHR. In this article, we
showed that optoFGFR1 can regulate the signaling path-
ways of FGFR by blue light in a rapid and reversible manner
with subcellular resolution. OptoFGFR1 also induces cell
polarization, changes in the cytoskeleton, and directed cell
migration by light illumination. Through migration experi-
ments using optoFGFR1, we revealed that the PI3K and
PLCg pathways contribute differently to the directionality
of endothelial cell migration and that FGFR signals affect
both the directionality and speed of migrating cells. These
results demonstrate that optoFGFR1 can be used to study
numerous biological systems in which FGFR signals are
involved, such as development, cancer, and angiogenesis.
With growing interest regarding the role of FGFs, not only
as typical growth factors but also as endocrine hormones,
optoFGFR1 will be a valuable tool addressing needs in
FGFR biology in vitro and in vivo.EXPERIMENTAL PROCEDURES
Plasmids
For construction of optoFGFR1, the PHR domain from the CRY2PHR-mCherry
vector (Kennedy et al., 2010) (provided by C. L. Tucker, University of Colorado
Denver) was codon optimized (Lee et al., 2014), amplified byPCR, and inserted
into the pmCitrine-N1 and pmCerulean-N1 vectors (Clontech). The cyto-
plasmic region of FGFR1 (amino acids 398–822) was isolated by RT-PCR
with human brain total RNA (Clontech) and verified by sequencing. The myris-
toylation sequence was added to the N terminus of CRY2PHR, and the cyto-
plasmic region of FGFR1 was inserted between the myristoylation sequence
and CRY2PHR using the In-Fusion cloning system (Clontech) according to910 Chemistry & Biology 21, 903–912, July 17, 2014 ª2014 Elsevier Lthe manufacturer’s instructions. Site-directed mutation of Y766F in FGFR1
and D387A in CRY2PHR was done by multiple steps of PCR. The mCherry-
Lifeact vector was constructed by inserting the Lifeact peptide sequence
(Riedl et al., 2008) into the pmCherry-C1 vector (Clontech). The fluorescent
protein sequence of yellow fluorescent protein (YFP)-PHAKT1 (Pleckstrin
homology domain of AKT1) (Park et al., 2008; Yang et al., 2012) and ERK1-
YFP (Alliance for Cellular Signaling) were replaced with dTomato from
pThy1-Brainbow-1.0 L (Addgene, catalog no. 18725). Wild-type RAB5b was
obtained from a small GTPase library (Heo and Meyer, 2003), cloned by
PCR, and inserted into mRFP-C1. Chemically induced FGFR1 (ihFGFR1)
was constructed based on the design of a previous study (Welm et al.,
2002). In brief, the FK506 binding protein mutant (FKBP(36V)) in the pSH1/
M-FGFR1-Fv-Fvls-E vector (Addgene, catalog no. 15285) was amplified by
PCR, and the CRY2PHR region of optoFGFR1 plasmid was replaced with
the two tandem repeats of FKBP(36V) using the In-Fusion cloning system.
pCMV-R-GECO1 (catalog no. 32444) (Zhao et al., 2011) and pCMV-VSV-G
(catalog no. 8454) were purchased from Addgene. The pLNCX2 vector was
purchased from Clontech.
Cell Culture and Reagents
HeLa cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
(catalog no. 11995-065, Gibco) containing 10% fetal bovine serum (catalog
no. 26140-079, Gibco) at 37C with 10% CO2. HUVECs (catalog no. C-003-
5C, Gibco) were maintained in medium 200 (catalog no. M-200-500, Gibco)
supplemented with 2% low-serum growth supplement (catalog no. S-003-
10, Gibco) at 37C with 5% CO2. HUVECs between passages 5 and 9 were
used for experiments. Transfection was conducted with the Neon transfection
system (catalog no. MPK5000, Invitrogen) or Lipofectamine LTX (catalog no.
15338-100, Invitrogen) according to the manufacturer’s instructions. In the
case of HUVECs, the plate bottom was coated with 300 mg/ml of bovine
collagen solution (PureCol, catalog no. 5005-B, Advanced BioMatrix) for 1 hr
at 37C before plating. Six hours before the experiments, serum starvation
was performed with serum-free DMEM for HeLa cells or with human endothe-
lial serum-free medium (catalog no. 11111-044, Gibco) containing 0.1%
bovine serum albumin for HUVECs. A total of 10 ng/ml of bFGF (catalog no.
100-18B, PeproTech), 50 nM of PD0325901 (catalog no. 391210-10-9,
Caymanchem), 50 mM of LY294002 (catalog no. L-7962, LC Laboratories),
20 mM of SU5402 (catalog no. 3300, Tocris), and 100 nM of AP20187 (catalog
no. 635060, Clontech) was used for experiments. Inhibitors were added 30min
before the experiment.
Generation of a Stable Cell Line
BOSC 23 retroviral packaging cells (Pear et al., 1993) were plated onto a
60-mm dish 24 hr before transfection. Either the pLNCX2-R-GECO1 or
pLNCX2-optoFGFR1 plasmid was transfected with pCMV-VSV-G into BOSC
23 cells (1:2 ratio) using Lipofectamine LTX following the manufacturer’s
instructions. After 48 hr, media containing retroviral particles were filtered
through a 0.45-mm syringe filter (catalog no. 16555, Sartorius) and mixed
with 8 mg/ml of Polybrene (catalog no. S2667, Sequa-brene, Sigma-Aldrich).
The supernatant mixture was added to confluent HeLa cells in 100-mmdishes.
Infected cells were transferred to 100-mm dishes at densities of 6 3 103 to
2.4 3 104 cells/dish and treated with 500 mg/ml of G418 (catalog no.
G-1033, AG Scientific) for 2 weeks until clonal isolation.
Immunoblot Analysis
HeLa cells stably expressing optoFGFR1 were grown on 6-well plates and
stimulated with an array of light-emitting diodes (LEDs) with 5.5 mW of
488 nm wavelength (Live Cell Instruments). Whole cell lysates were prepared
in the dark room, harvested in ice-cold Dulbecco’s phosphate-buffered saline
(DPBS), and lysed with Pro-PREP solution (catalog no. 17081, iNtron
Biotechnology). 30 mg of total protein was loaded onto a 4%–12% gradient
polyacrylamide gel (catalog no. NP0322BOX, Invitrogen). After electropho-
resis, proteins were transferred onto nitrocellulose membrane using the iBlot
gel transfer device (catalog no. IB1001, Invitrogen). Membranes were stripped
with BlotFresh Western blot stripping buffer (catalog no. SL100324, SignaGen
Laboratories) before blotting with b-actin to remove signals from phospho-
ERK1/2 and ERK1/2. Antibodies and related reagents used for immunoblot
were phospho-FGFR1 Tyr653/654 (catalog no. 3476S, Cell Signalingtd All rights reserved
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A5316, Sigma), phospho-ERK1/2 (catalog no. 9101S, Cell Signal), ERK1/2
(catalog no. 4696, Cell Signal), anti-mouse IR Dye 800CW (catalog no. 926-
32210, LI-COR Biosciences), anti-rabbit IR Dye 600CW (catalog no. 926-
68071, LI-COR Biosciences), and Odyssey blocking buffer (catalog no.
927-40000, LI-COR Biosciences). Protein bands were visualized using
ODYSSEY CLx (catalog no. P/N 9140-WP, LI-COR Biosciences).
Live Cell Imaging and Photoactivation
Prepared cells were spread onto plastic-bottom, 96-well plates (catalog no.
89626, Ibidi) for live cell imaging. Live cell imaging was conducted with a Nikon
A1R confocal microscope with CFI PlanApo objectives under 603 magnifica-
tion for single cell imaging or 203 for monitoring cell migration. Lasers of
457 nm (cyan), 514 nm (yellow), and 561 nm (red) were used for acquisition of
multicolor images. For FRET analysis, emission ratio imaging was performed
with a 457-nm excitation laser/535-nm emission YFP HYQ filter (catalog no.
96345, Nikon).
Photoactivation was conducted with a 488-nm laser emitted through a
Galvano scanner incorporated in ahybrid confocal scanheadwithahigh-speed
hyper selector (Nikon). The shape and size of the photoactivating region was
adjusted by Nikon imaging software (NIS-element AR, Laboratory Imaging).
The intensity of the activation laser was measured on the focus plane with an
optical power meter (catalog no. 8230E, ADCMT). The activation intensity of
the laser varied from 1–50 mW, which corresponds to 1.30–64.94 mW/cm2.
A Nikon Ti-E TIRF microscope equipped with a CFI Apochromat TIRF 603
objective was used to specifically visualize plasma membrane fluorescence.
The excitation light was produced from a directly doubled laser for GFP
(488 nm) (CVI-Melles Griot). Emission filter fluorescein isothiocyanate (FITC)
HYQ (catalog no. 96320, Nikon) was used for GFP, and an electron-multiplying
charge-coupled device camera (catalog no. C9100-02, Hamamatsu Pho-
tonics) was used as a detector.
Image Analysis and Statistical Analysis
Image data were analyzed by Nikon imaging software (NIS-element AR,
Laboratory Imaging) and MetaMorph 7.7 (Molecular Devices). Plotting inten-
sity of ERK-dTomato, dTomato-PHAKT, and R-GECO1 versus time (t) yielded
a sigmoidal curve that was fitted to a four-parameter logistic function, gener-
ally expressed by the following equation (Dudley et al., 1985):
IntensityðtÞ=A + B A
1+

t
T1=2
C; (Equation 1)
where A, B, C, and T1/2 denote the minimum asymptote, maximum asymptote,
steepness of curve, and inflection point, respectively. Nonlinear curve fitting
was performed using the Solver tool in Microsoft Excel.
In the duty cycle experiment, we converted the duration of photostimulation
into a duty cycle with the following equation, where T is the time period of
stimulation and P is the total period of the signal:
Duty cycleðDÞ=T
P
3 100 %: (Equation 2)
MetaMorph 7.7 was used to quantify actin bundles in migrating HUVECs. To
subtract noisy signals of the Lifeact biosensor, we used a binary operator in
the software. A binarization process was applied to the original image to clearly
visualize the linear actin pattern. The subtracted linear actin signals were
measured and integrated into numerical values. Tracking of migrating cells
was performed with a journal of multidimensional motion analysis in
MetaMorph 7.7. Statistical comparisons were performed with an unpaired,
two-tailed Student’s t test using Microsoft Excel. SEM was used to indicate
error bars in the figures.
Cell Viability Assay
OptoFGFR1 expressing or not expressing HeLa cells and HUVECs was plated
on plastic-bottom, 96-well plates and illuminated by an LED array for 24 hr
(488 nm, 25 mW, 5 min intervals). After light exposure, the cells were stained
with LIVE/DEAD reagent (2 mMcalcein-acetoxymethyl ester and 4 mMethidium
homodimer 1, catalog no. L-3224, Invitrogen) and incubated at 37C for
30 min, followed by washing with DPBS. The images of stained cells wereChemistry & Biology 21,captured with Image Express XL (Molecular Devices). The number of live
and dead cells was counted from four randomly selected fields for each con-
dition. Cell viability was calculated as the percentage of the number of green
fluorescence-stained cells of total cells.
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